Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-06 Sale | 2026-04-07 4:50 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne President and CEO | 72,559 | $9.156 | $664,350 | 1,001,263 (Indirect Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:54 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 14,762 | $9.5326 | $140,720 | 1,073,822 (Indirect Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:09 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 19,039 | $7.4528 | $141,894 | 1,658,584 (Indirect Direct) | View |
| 2025-04-03 Sale | 2025-04-04 4:23 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 79,712 | $5.9494 | $474,239 | 822,623 (Indirect Direct) | View |
| 2025-02-24 Sale | 2025-02-25 3:36 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 16,122 | $9.4534 | $152,408 | 1,382,335 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-04 4:14 pm | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 72,995 | $9.4577 | $690,365 | 678,457 (Direct) | View |
| 2022-01-03 Sale | 2022-01-04 9:31 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 4,500 | $64.71 | $291,177 | 17,000 (Direct) | View |
| 2021-12-01 Purchase | 2021-12-02 5:12 pm | Kronos Bio Inc. | KRON | De Backer Marianne Director | 1,150 | $11.57 | $13,306 | 2,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-29 Other | 2026-04-30 5:43 pm | N/A N/A | Vir Biotechnology Inc. | VIR | De Backer Marianne President and CEO | 233,532 | $0 | 1,468,327 (Direct) | View |
| 2026-02-22 Option Award | 2026-02-24 7:09 pm | N/A 2036-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 855,000 | $0 | 1,658,584 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-25 3:36 pm | N/A 2035-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 720,000 | $0 | 1,382,335 (Direct) | View |
| 2024-06-12 Other | 2024-06-12 4:00 pm | N/A N/A | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 53,118 | $0 | 784,693 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 7:32 pm | N/A 2034-02-21 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 525,000 | $0 | 1,101,452 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:11 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-04 4:53 pm | N/A 2033-04-02 | Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer | 1,729,356 | $0 | 1,729,356 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:38 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 12,460 | $0 | 35,860 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:14 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 28,333 | $0 | 31,083 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 8:07 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 6,400 | $0 | 23,400 (Direct) | View |